Počet záznamov: 1
skúšanie klinické, fáza III, ako téma
SYS d017326 LBL 00000cz--a2200000n--4500 005 20250606213316.1 008 920513|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $d BA006 065 $a E05.318.372.250.250.220 065 $a N05.715.360.330.250.250.220 065 $a N06.850.520.450.250.250.220 066 $a 01 $c 03 089 $a 615.036 $v UDC-MRF-SK3 $z slo 150 $a skúšanie klinické, fáza III, ako téma $x CL $x EC $x ES $x HI $x IS $x LJ $x MT $x PX $x SN $x ST $x VE $2 slo 450 $w v $a pokusy klinické, tretia fáza, ako téma $2 slo 450 $w v $a testy klinické, tretia fáza, ako téma $2 slo 450 $w v $a štúdie klinické, fáza III, ako téma $2 slo 550 $7 sllk_us_auth*d015337 $Y Multicenter Studies as Topic $w b $a štúdie multicentrické ako téma 665 $a 2008(1993) $2 eng 665 $a Clinical Trials (1980-1992) $2 eng 680 9-
$i Works about comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries. $2 eng 680 $a for general design, methodology, economics, etc. of phase III clinical trials; a different heading CLINICAL TRIAL, PHASE III is used for reports of a specific phase III clinical trial $2 eng 750 -2
$a Clinical Trials, Phase III as Topic $2 eng 980 $x M
Počet záznamov: 1